LivaNova presents at Morgan Stanley Global Healthcare ConferencePUBT·Sep 3 at 01:02 PMMS+0.26%LIVN+0.89%
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stockbenzinga_article·Aug 14 at 03:04 PMLIVN+0.89%
LivaNova Chief Innovation Officer Ahmet Tezel disposes of shares worth $435,409.36PUBT·Aug 13 at 08:05 PMLIVN+0.89%
LivaNova PLC 2Q 2026: Revenue $390.59M, EPS $1.93— 10-Q SummaryTradingView·Aug 5 at 06:31 PMLIVN+0.89%
LIVN: Double-digit revenue growth and a return to profitability, driven by segment expansion and cost controlsQuartr·Aug 5 at 06:28 PMLIVN+0.89%
LivaNova Q2 FY26 GAAP diluted EPS rises to $1.93; revenue increases 10.8% year over year to $390.6 millionPUBT·Aug 5 at 10:13 AMLIVN+0.89%TMO-0.75%
LIVN: Revenue and EPS guidance raised on strong segment growth; strategic investments impact cash flowQuartr·Aug 5 at 10:08 AMLIVN+0.89%
LivaNova says Cardiopulmonary President Stefano Folli files initial beneficial ownership statementPUBT·Aug 5 at 10:07 AMLIVN+0.89%
Livanova | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 390.6 MEarnings Watch·Aug 5 at 10:07 AMLIVN+0.89%
LivaNova Reports Second-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance | LIVN Stock NewsStockTitan·Aug 5 at 02:00 AMLIVN+0.89%TMO-0.75%
